Alexandra Weiss MD, Edward L Barnes MD MPH, Meenakshi Bewtra MD PhD MPH A Practical Guide to the Use of Upadacitinib in Ulcerative Colitis and Crohn's disease , American Journal of Gastroenterology: 2024
James D Lewis, Lauren E Parlett, Michele L Jonsson Funk, Colleen Brensinger, Virginia Pate, Qufei Wu, Ghadeer K Dawwas, Alexandra Weiss, Brad D Constant, Maureen McCauley, Kevin Haynes, Jeff Yufeng Yang, Douglas E Schaubel, Andres Hurtado-Lorenzo, Michael David Kappelman Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States , Gastroenterology : 2023
Thanawala S, Weiss AH, Weber A, Tang H, Buchner A. The role of liver transplant in the development of colorectal dysplasia in patients with PSC-IBD. (Poster Presentation) , DDW: 2023
Weiss AH, Thanawala S, Tang H, Weber A, Buchner A. Severity of inflammation as a risk factor for the development of colorectal dysplasia in PSC-IBD. (Poster Presentation) , DDW: 2023
Khan N, Pernes T, Weiss A, Trivedi C, Patel M, Medvedeva E, Xie D, Yang YX Efficacy of Vedolizumab in a nationwide cohort of elderly inflammatory bowel disease patients , Inflammatory Bowel Diseases : 2022
Weiss, A.H. and Buchner, A.M Editorial: colorectal cancer in elderly-onset inflammatory bowel disease—what is the risk? , Aliment Pharmacol Ther, 56(9): 2022,1421-1422
Mahmud N, Weiss A, Trivedi C, Yang YXm Lewis J, Khan N Risk of venous thromboembolism among patients with inflammatory bowel disease who contract severe acute respiratory syndrome Coronavirus 2 , Gastroenterology, 161: 2021
Weiss AH, Trivedi C, Pernes T, Patel M, Khan N. Efficacy of vedolizumab in a nationwide cohort of elderly inflammatory bowel disease patients. (Poster Presentation) , DDW : 2021
Weiss AH, Bhattacharya A, Ellison S, Osterman MT, Lichtenstein G Lower Adalimumab trough levels are associated with higher risk of infectious complications in patients with IBD , DDW : 2021
Weiss AH, Trivedi C, Pernes T, Patel M, Khan N Incidence of infections and malignancy among elderly IBD patients exposed to vedolizumab, prednisone and mesalamine (Poster Presentation) , DDW : 2021